Musculoskeletal News and Research

RSS

Long-term side effects of modern treatment for rheumatoid arthritis

Janus kinase inhibitors (JAKi) and biologics are the cornerstone of modern treatment for rheumatoid arthritis (RA). But there have been concerns over long-term side effects.

1 Jun 2023

EULAR launches unique resource of facts and figures related to RMDs across Europe

The European Alliance of Associations for Rheumatology (EULAR) is proud to announce the launch of RheumaFacts, an innovative and unique resource of facts and figures related to rheumatic and musculoskeletal diseases (RMDs) across Europe.

1 Jun 2023

EULAR announces the launch of new survey targeted directly at RMD patients

The European Alliance of Associations for Rheumatology has announced the launch of the EULAR Impact of RMDs Survey, an online questionnaire targeted directly at RMD patients.

1 Jun 2023

Rheumatic and musculoskeletal diseases increase the risk of lethal comorbidities

Rheumatic and musculoskeletal diseases (RMDs) include over 200 diseases that affect over 120 million Europeans of all ages.

1 Jun 2023

Systematic approach needed to identify mental health issues in patients with inflammatory arthritis

Anxiety and depression are the mental health issues most commonly associated with inflammatory arthritis, and it is well-established that there is a link between mental health issues and poor health outcomes.

1 Jun 2023

Association between healthy lifestyle and mortality in people with osteoarthritis

In this work, data from the UK Biobank were used to investigate the association of both individual and combined healthy lifestyle factors with the risk of all-cause and cause-specific mortality among 104,142 people with osteoarthritis.

1 Jun 2023

Increased risk of cardiovascular disease in psoriatic arthritis patients

Patients with psoriatic arthritis (PsA) have an increased risk of cardiovascular disease, possibly due to a chronic inflammatory state.

1 Jun 2023

Special issue aims to deepen the conversation around cerebral palsy

Although cerebral palsy (CP) is the most common childhood-onset disability, there are very few evidence-based clinical practice guidelines or recommendations on how to treat and manage this condition.

31 May 2023

NIH scientists identify genomic variants that cause rare inflammatory skin disorder

Researchers at the National Institutes of Health and their colleagues have identified genomic variants that cause a rare and severe inflammatory skin disorder, known as disabling pansclerotic morphea, and have found a potential treatment.

31 May 2023

Personalized video exercises may be useful to support rehabilitation for people with RMD

Apps have become ubiquitous in many parts of life, including for health. For people with an RMD, personalized video exercises (PEV) may be useful to support rehabilitation and physical exercise.

31 May 2023

Breaking barriers to improve access to quality information about lupus

In general, there is an issue around the quality of information about lupus on the internet. Rumors, unchecked data, and unconfirmed research all contribute to confusion and anxiety, and can lead to people taking the wrong actions for themselves and their disease.

31 May 2023

Factors associated with diagnostic delay in Familial Mediterranean Fever

EULAR – The European Alliance of Associations for Rheumatology – held its 2023 annual congress in Milan, Italy. One of the abstracts chosen for presentation in the scientific session on Rheumatic and Musculoskeletal diseases (RMDs) in children and young people, focused on the factors associated with diagnostic delay in FMF, using data from the Juvenile Inflammatory Rheumatism (JIR) cohort.

31 May 2023

AI interpretations of MRI images could provide more accurate RA prediction

Early inflammatory arthritis is often undifferentiated, but it may develop into established RA or another arthropathy.

31 May 2023

Cardiovascular comobidities in RA patients

The increased cardiovascular risks in RA include acute coronary syndromes (ACS). The extent to which DMARD-induced remission could reduce the risk of ACS in RA versus rates in the general population – and whether there are DMARD-specific beneficial effects on ACS risk – remain unknown.

31 May 2023

Long-term consequences of COVID-19 in patients with inflammatory rheumatic diseases

Studies on the long-term consequences of COVID-19 (long-COVID) in patients with inflammatory rheumatic diseases (iRD) are scarce.

31 May 2023

Burden of autoimmune disease continues to increase over time, research suggests

EULAR – the European Alliance of Associations for Rheumatology – works on a broad spectrum of autoimmune and auto-inflammatory diseases.

31 May 2023

A deeper look into axial spondyloarthritis: Prevalence, diagnosis, and treatment

There is a large diagnostic delay for people with axial spondyloarthritis (axSpA). In 2008, the SPACE cohort started to assess the prevalence of axSpA – and the reliability of an early diagnosis in people with chronic back pain (CBP).

31 May 2023

Health outcomes and costs remain the same for patients treated by allopathic or osteopathic physicians

New UCLA-led research suggests that patient mortality rates, readmissions, length of stay, and health care spending were virtually identical for elderly hospitalized patients who were treated by physicians with Doctor of Medicine (MD) or Doctor of Osteopathic Medicine (DO) degrees.

29 May 2023

New standards for the training of rheumatologists across Europe

Postgraduate rheumatology training programmes define the knowledge, skills, and behaviours needed for physicians to become specialists in rheumatology.

26 May 2023

Can ingesting products with different percentages of cocoa affect muscle pain sensation?

Researchers investigated whether consuming different cocoa products in different proportions could lower pain experimentally induced by injecting hypertonic saline into the masseter muscle of healthy individuals.

26 May 2023

Musculoskeletal News and Research

Long-term side effects of modern treatment for rheumatoid arthritis

EULAR launches unique resource of facts and figures related to RMDs across Europe

EULAR announces the launch of new survey targeted directly at RMD patients

Rheumatic and musculoskeletal diseases increase the risk of lethal comorbidities

Systematic approach needed to identify mental health issues in patients with inflammatory arthritis

Association between healthy lifestyle and mortality in people with osteoarthritis

Increased risk of cardiovascular disease in psoriatic arthritis patients

Special issue aims to deepen the conversation around cerebral palsy

NIH scientists identify genomic variants that cause rare inflammatory skin disorder

Personalized video exercises may be useful to support rehabilitation for people with RMD

Breaking barriers to improve access to quality information about lupus

Factors associated with diagnostic delay in Familial Mediterranean Fever

AI interpretations of MRI images could provide more accurate RA prediction

Cardiovascular comobidities in RA patients

Long-term consequences of COVID-19 in patients with inflammatory rheumatic diseases

Burden of autoimmune disease continues to increase over time, research suggests

A deeper look into axial spondyloarthritis: Prevalence, diagnosis, and treatment

Health outcomes and costs remain the same for patients treated by allopathic or osteopathic physicians

New standards for the training of rheumatologists across Europe

Can ingesting products with different percentages of cocoa affect muscle pain sensation?

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Top-Down Proteomics: Bridging the Genotype-to-Phenotype Gap

Latest News